Paliperidone
NDC 69367-435, Paliperidone, tablet, extended release, from Westminster Pharmaceuticals, LLC.
- Product NDC
- 69367-435
- Status
- Listed
- Labeler
- Westminster Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218755
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69367-435 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALIPERIDONE9 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69367-435-30 | 69367043530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-435-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1745a460-5e3a-4a1f-8eb3-64bb112f47a4NADAC price for package 69367043530
GET /v1/drugs/nadac/69367043530
Use it
Look up 69367-435 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69367-435 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69367-435. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.